neoplasm
|
• in of all doxycycline-treated mice arising from neural crest-lineage cells
|
Analysis Tools|
Allele Symbol Allele Name Allele ID |
Col1a1tm1(tetO-EWSR1/ATF1)Yasu targeted mutation 1, Yasuhiro Yamada MGI:5485192 |
||||||||||||||||
| Summary |
3 genotypes
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• in of all doxycycline-treated mice arising from neural crest-lineage cells
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• in of all doxycycline-treated mice arising from neural crest-lineage cells
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• after 3 to 10 months of doxycycline-treated mice with median survival of 20 weeks
|
|
• in doxycycline-treated mice following withdrawal of doxycycline
|
|
• in the trunks, heads, limbs, and whisker pads of all doxycycline-treated mice after 3 months arising from neural crest-lineage cells
|
|
• in doxycycline-treated mouse embryonic fibroblasts
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
| clear cell sarcoma | DOID:4233 | J:194505 | ||
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 09/30/2025 MGI 6.24 |
|
|
|
||


